Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Intangibles (2016 - 2021)

Capricor Therapeutics (CAPR) has 9 years of Intangibles data on record, last reported at $1083.0 in Q1 2021.

  • For Q1 2021, Intangibles fell 79.99% year-over-year to $1083.0; the TTM value through Mar 2021 reached $1083.0, down 79.99%, while the annual FY2020 figure was $2165.0, 66.67% down from the prior year.
  • Intangibles reached $1083.0 in Q1 2021 per CAPR's latest filing, down from $2165.0 in the prior quarter.
  • Across five years, Intangibles topped out at $130066.0 in Q1 2017 and bottomed at $1083.0 in Q1 2021.
  • Average Intangibles over 5 years is $48107.1, with a median of $38952.0 recorded in 2019.
  • The widest YoY moves for Intangibles: up 27.26% in 2017, down 92.95% in 2017.
  • A 5-year view of Intangibles shows it stood at $93048.0 in 2017, then crashed by 46.51% to $49772.0 in 2018, then plummeted by 86.95% to $6495.0 in 2019, then tumbled by 66.67% to $2165.0 in 2020, then plummeted by 49.98% to $1083.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Intangibles were $1083.0 in Q1 2021, $2165.0 in Q4 2020, and $3248.0 in Q3 2020.